CiVi Biopharma

About:

CiVi Biopharma is a clinical stage research and development biotechnology company whose mission is to create novel cardiovascular.

Website: https://www.civibio.com/

Top Investors: RA Capital Management, Boxer Capital, Roche Venture Fund, Tang Capital Management

Description:

CiVi Biopharma is a clinical stage research and development biotechnology company whose mission is to create novel cardiovascular and metabolic therapies that have meaningful value to patients. The company has multiple assets in various stages of development including Intravenous Iloprost in Phase 3 trials for treatment of Systemic Sclerosis.

Total Funding Amount:

$89M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Chevy Chase, Maryland, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)civibio.com

Founders:

Henrik Orum, Jess Thiersen

Number of Employees:

11-50

Last Funding Date:

2018-05-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai